✦ LIBER ✦

Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population

✍ Scribed by James McCarty; Gary E. Ruoff; Kirk D. Jacobson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loracarbef (LY163892) versus cefaclor an

✍ David L. Hyslop; Werner Bischoff 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 852 KB

Safety and efficacy of lomefloxacin and

✍ Amaya-Tapia, G.; Andrade-Villanueva, J.; Flores-Gaxiola, A.; Aguirre-Avalos, G.; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 780 KB

Ceftaroline Fosamil in the Treatment of

✍ Dr Thomas P. Lodise PharmD, Donald E. Low 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 256 KB

Loracarbef versus penicillin VK in the t

✍ James McCarty 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Population pharmacokinetics of ceftaroli

✍ Van Wart, Scott A.; Forrest, Alan; Khariton, Tatiana; Rubino, Christopher M.; Bh 📂 Article 📅 2013 🏛 Sage Publications 🌐 English ⚖ 890 KB

Treatment of skin and skin structure inf

✍ John N. Sheagren 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 868 KB